MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Todays Market
- Indian Stock Market Updates March 20, 2020
NATCO PHARMA Surges by 8%; BSE HEALTHCARE Index Up 3.9%
Fri, 20 Mar 09:28 AM
NATCO PHARMA share price has zoomed 8% and is presently trading at Rs 544.
Meanwhile, the BSE HEALTHCARE Index is at 11,853 (up 3.9%).
Among the top Gainers in the BSE HEALTHCARE Index today are NATCO PHARMA (up 7.8%) and IPCA LABS (up 14.9%).
ERIS LIFESCIENCES LIMITED (down 1.5%) and SHILPA MEDICARE (down 5.0%) are among the top losers today.
Over the last one year, NATCO PHARMA has moved down from Rs 598 to Rs 544, registering a loss of Rs 54 (down 9.0%).
On the other hand, the BSE HEALTHCARE has moved down from 14,270 to 11,853, loss of 2,417 points (down 17.0%) during the last 12 months.
The top gainers among the BSE HEALTHCARE Index stocks during this same period were ABBOTT INDIA (up 88.2%), J.B.CHEMICALS (up 60.4%) and IPCA LABS (up 57.3%).
Revealed: 3 Stocks for Potentially Massive Gains
What About the Benchmark Indices?
The BSE Sensex is at 28,687 (up 1.2%).
The top gainers among the BSE Sensex stocks today are POWER GRID (up 6.2%), ONGC (up 5.9%) and ITC (up 5.1%). Other gainers include BAJAJ AUTO (up 5.0%) and SUN PHARMA (up 4.4%). The most traded stocks in the BSE Sensex are SBI and ONGC.
In the meantime, NSE Nifty is at 8,441 (up 1.9%). The top gainers in the NSE Nifty include GAIL (up 7.9%), YES BANK (up 6.1%) and POWER GRID (up 5.6%). Other gainers include ONGC (up 5.6%) and JSW STEEL (up 5.1%) are among the top gainers in NSE Nifty.
Over the last 12 months, the BSE Sensex has moved down from 38,363 to 28,687, registering a loss of 9,676 points (down 25.36%).
NATCO PHARMA Financial Update...
NATCO PHARMA net profit down at Rs 1 billion for the quarter ended December 2019, compared to a loss of Rs 2 billion a year ago. Net Sales declined 13.4% to Rs 4.8 billion during the period as against Rs 5.6 billion in October-December 2018.
For the year ended March 2019, NATCO PHARMA reported 7.6% decrease in net profit to Rs 6.4 billion compared to net profit of Rs 7.0 billion during FY18.
Revenue of the company grew 4.9% to Rs 21 billion during FY19.
The current Price to earnings ratio of NATCO PHARMA, based on rolling 12 month earnings, stands at 4.1x.
Indian Share Market Update: Top Gainers and Losers
What else is happening in the markets today? Dig in...
- TRACK NOW:
- Most Active Stocks Rs 0 to 10
- Most Active Stocks Rs 10 to 20
- Top Gainers Today BSE A Group
- Top Gainers Today NSE Above Rs 20
- Top Gainers Today BSE Above Rs 20
- Top Gainers Today BSE Sensex
- Top Gainers Today BSE Small Cap
- Top Gainers Today BSE 500
- Top Losers Today BSE A Group
- Most Active Stocks Rs 1 to 2
- Top Losers Today NSE Above Rs 20
- Buzzing Stocks Today
- Most Popular Stocks BSE 30
- TRENDING ON EQUITYMASTER:
- Warren Buffett - The Value Investor
- Your Ultimate Guide to Penny Stock Investing
- How to Invest in Gold
- Basics of Value Investing
- Benjamin Graham
- The Best Bluechip Stocks to Buy
- How to Invest in Silver
- The Best Small-cap Stocks to Buy
- 10 Rules for Successful Long-Term Investing
- How to Invest in the Share Market
- Best Stocks to Buy Today
- How to Use P/E for Successful Investing
- How to Find Undervalued Stocks
- Differences Between Trading and Investing
- SWOT Analysis for Stocks
- The Best Dividend Stocks to Buy
Stock Market Updates
RAIN INDUSTRIES Share Price Down by 6%; BSE 500 Index Down 2.6% (Today's Market)
Apr 12, 2021 10:00 AMRAIN INDUSTRIES share price is trading down by 6% and its current market price is Rs 164. The BSE 500 is down by 2.6%. The top gainers in the BSE 500 Index are JUBILANT PHARMOVA (up 6.2%) and IPCA LABS (up 5.3%). The top losers are RAIN INDUSTRIES (down 5.8%) and BAJAJ FINANCE (down 5.1%).
Sensex Slumps 1,400 Points, Nifty Cracks Below 14,400; IndusInd Bank & SBI Fall 8% (Today's Market)
Apr 12, 2021 09:30 amAsian stock markets are trading on a cautious note today as investors wait to see if US earnings can justify sky-high valuations.
VOLTAS Share Price Down by 6%; BSE CONSUMER DURABLES Index Down 4.0% (Today's Market)
Apr 12, 2021 09:39 AMVOLTAS share price is trading down by 6% and its current market price is Rs 994. The BSE CONSUMER DURABLES is down by 4.0%. The top losers are VOLTAS (down 6.2%) and SYMPHONY (down 5.9%).
VA TECH WABAG Share Price Down by 7%; BSE CAPITAL GOODS Index Down 3.7% (Today's Market)
Apr 12, 2021 09:39 AMVA TECH WABAG share price is trading down by 7% and its current market price is Rs 254. The BSE CAPITAL GOODS is down by 3.7%. The top losers are VA TECH WABAG (down 6.9%) and HEG (down 7.8%).
SHRIRAM TRANSPORT Share Price Down by 8%; BSE 500 Index Down 3.2% (Today's Market)
Apr 12, 2021 09:39 AMSHRIRAM TRANSPORT share price is trading down by 8% and its current market price is Rs 1,412. The BSE 500 is down by 3.2%. The top gainers in the BSE 500 Index are GSK CONSUMER (up 5.1%) and JUBILANT PHARMOVA (up 5.0%). The top losers are SHRIRAM TRANSPORT (down 8.0%) and BAJAJ FINANCE (down 6.4%).
J&K BANK Share Price Down by 6%; BSE BANKEX Index Down 4.3% (Today's Market)
Apr 12, 2021 09:38 AMJ&K BANK share price is trading down by 6% and its current market price is Rs 26. The BSE BANKEX is down by 4.3%. The top losers are J&K BANK (down 6.5%) and INDUSIND BANK (down 8.2%).
View More Indian Share Market NewsMost Popular
A Critical Update on the Market(Fast Profits Daily)
Mar 30, 2021In this video, I'll tell you why I am recommending caution in the market at this time.
My Recent Recommendation Will Profit from the Global Supply Chain Crisis(Profit Hunter)
Mar 31, 2021A tiny chemical company, started in the Licence Raj era, is a great example of a new wealth creating opportunity.
My Stock Trading Strategy(Fast Profits Daily)
Mar 31, 2021In this video I'll show you exactly how I go about picking stocks for trading.
What You Need to Find Hundred Baggers(Profit Hunter)
Mar 30, 2021100 baggers of the last decade share this common trait. Here's how to use it to nail future multibaggers.
MoreOUR TOP 5 IDEAS
- India's Revival: A Once-in-a-generation Wealth Making Opportunity
- Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
- Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
- Free Report: The Secret to Increasing Your Trading Profits Daily!
- No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.
S&P BSE SENSEX
Apr 12, 2021 10:26 AM
MARKET STATS
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
- Basics of Value Investing
- Benjamin Graham
- How to Invest in Gold
- How to Invest in Silver
- Best Stocks to Buy Today
- Warren Buffett - The Value Investor
- The Best Small-cap Stocks to Buy
- The Best Bluechip Stocks to Buy
- Your Ultimate Guide to Penny Stock Investing
- 10 Rules for Successful Long-Term Investing
- How to Invest in the Share Market
- Momentum Moves
FOLLOW
APP
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
Equitymaster requests your view! Post a comment on "NATCO PHARMA Surges by 8%; BSE HEALTHCARE Index Up 3.9%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!